Executive Summary
The November 9, 2026 M&A digest is dominated by SPAC extension mechanics and small-cap strategic deals, with 9 of 15 filings involving blank-check vehicles.
The most material event is Abeona Therapeutics' stock-funded acquisition of ABO-801 for up to $80M plus royalties, paired with a $30M private placement at $3.75—yet the asset's two Phase 3 misses on the patient-reported endpoint introduce binary risk. Reliance Global Group closed its $3.75M GPU cloud asset purchase, entering AI infrastructure with a tiny $1.5M revenue base and explicit dilution risk. Park Dental added 12 practices and 47 doctors in North Carolina, expanding to 100 locations and 270 doctors, but withheld deal terms until its November 12 earnings release. SPAC activity shows stress: FACT II seeks a one-year extension with a $10.81 redemption price and non-redemption incentives, Launch One faces Nasdaq noncompliance after a director resignation, and Future Vision II disclosed a listing deficiency. Insider/board turnover at Roman DBDR and Launch One, plus withheld votes at Flag Ship, signal governance friction across the SPAC cohort. Overall, the period features a mix of small, stock-heavy deals and procedural SPAC updates, with limited period-over-period financial data disclosed—investors should focus on near-term catalysts: Park Dental's November 12 earnings, Abeona's Phase 3 redesign, and multiple SPAC votes between November 13-17.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K · DEFM14A
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from November 06, 2026.
Investment Signals (12)
- Abeona Therapeutics ↓ (BULLISH)▲
Acquired ABO-801 for $20M stock plus up to $60M milestones and low-to-mid-teens royalties, funded by a $30M private placement at $3.75 with top-tier healthcare funds (Nantahala, Marshall Wace, Perceptive, TPG)
- Reliance Global Group ↓ (MIXED)▲
Closed GPU cloud asset acquisition for $3M cash plus up to $750K earnout, debt-free post-deal, but acquired revenue base only ~$1.5M TTM and management flags potential dilutive equity financing to scale
- Park Dental Partners ↓ (BULLISH)▲
Expanded to 100 locations and 270 doctors with Village Family Dental acquisition (12 practices, 47 doctors), entering fourth state; deal terms and 2026 guidance due November 12 earnings
- JATT II Acquisition Corp. ↓ (NEUTRAL)▲
Definitive proxy for $120M all-stock merger with Talawar at $10.00 deemed per share; closing conditions include Nasdaq listing and minimum cash—watch vote and redemption levels
- Inflection Point Acquisition Corp. VI ↓ (NEUTRAL)▲
Quantum Space Analyst Day on November 9 and effective S-4 (Oct 28) position the deal for a near-term shareholder vote; no financial terms disclosed
- FACT II Acquisition Corp. ↓ (NEUTRAL)▲
Seeking one-year extension to November 25, 2027, with $10.81 redemption price and sponsor non-redemption agreements to stem outflows—extension vote November 17
- Kochav Defense Acquisition Corp. ↓ (BULLISH)▲
Sponsor increased first-3-month contribution to a flat $300K (from $0.06/share capped at $300K) and $100K/month thereafter, tightening trust protection by cutting dissolution withdrawal to $0—signals commitment to extension
- Flag Ship Acquisition Corp ↓ (BEARISH)▲
AGM passed all proposals with 81.1% quorum, but three of four director nominees received ~4.4% withheld votes vs 0.03% for the chair—governance dissent signal
- Launch One Acquisition Corp. ↓ (BEARISH)▲
Two Nasdaq noncompliance notices (audit committee size, board independence) after director resignation; no replacement named—cure timing uncertain
- Future Vision II Acquisition Corp. ↓ (BEARISH)▲
Item 3.01 listing deficiency notice with no deal economics disclosed—negative overhang on SPAC
- Haymaker Acquisition Corp V ↓ (NEUTRAL)▲
Unit separation effective November 9 enables separate trading of Class A shares (HAYC) and warrants (HYACW)—liquidity event but no deal announcement
- SPACCircle Acquisition Corp. ↓ (NEUTRAL)▲
Unit separation effective November 10 (SCQC, SCQCW, SCQCR)—routine administrative step, no merger disclosed
Risk Flags (10)
- Abeona Therapeutics↓ [HIGH RISK]▼
Both completed Phase 3 studies of ABO-801 missed the prespecified co-primary patient-reported symptom endpoint despite endoscopic improvements; new Phase 3 starts Q2 2027 with topline by end-2028—binary regulatory and clinical risk
- Reliance Global Group↓ [HIGH RISK]▼
Acquired GPU cloud business generated only ~$1.5M revenue TTM; scaling requires capital beyond the $3M cash outlay and may involve dilutive equity—execution and financing risk
- Launch One Acquisition Corp.↓ [HIGH RISK]▼
Audit committee reduced to two members (below Nasdaq's three-member requirement) and board no longer majority independent; no replacement director named and no assurance on timing—potential delisting if not cured
- Future Vision II Acquisition Corp.↓ [HIGH RISK]▼
Item 3.01 notice of failure to satisfy a continued listing rule or standard; deal terms, counterparty, and valuation undisclosed—listing and deal uncertainty
- FACT II Acquisition Corp.↓ [MEDIUM RISK]▼
Extension requires shareholder approval and redemption mitigation; $10.81 redemption price on ~$189M trust implies potential heavy outflows if non-redemption incentives are not offered—deal completion risk
- Flag Ship Acquisition Corp↓ [MEDIUM RISK]▼
Three director nominees received 120,999 withheld votes each (~4.4% of votes cast) vs 994 for Matthew Chen—shareholder dissent could complicate future proposals
- Roman DBDR Acquisition Corp. II↓ [MEDIUM RISK]▼
Director Randolph C. Read resigned from board and audit/compensation committees effective November 4; no disagreement cited, but board turnover during SPAC search period warrants monitoring
- Kochav Defense Acquisition Corp.↓ [MEDIUM RISK]▼
Extension EGM on November 13 requires shareholder approval; sponsor funding commitment increased but trust withdrawal for dissolution cut to $0—if extension fails, liquidation risk
- JATT II Acquisition Corp.↓ [MEDIUM RISK]▼
Closing conditioned on Nasdaq listing approval, Minimum Cash Condition, and no material adverse effects; outside date and 30-day cure periods—deal may fail if cash condition not met
- SPAC Sector [SECTOR RISK]▼
9 of 15 filings are SPAC-related, with multiple extensions, noncompliance notices, and board resignations—reflects a challenging environment for blank-check vehicles nearing deadlines
Opportunities (10)
- Abeona Therapeutics↓ (OPPORTUNITY)◆
$30M private placement at $3.75 with participation from top healthcare funds (Nantahala, Marshall Wace, Monashee, Perceptive, TPG) signals institutional conviction in ABO-801 despite Phase 3 misses; FDA Orphan Drug and Fast Track designations may ease path
- Park Dental Partners↓ (OPPORTUNITY)◆
Acquisition expands footprint to 100 locations and 270 doctors across four states; deal terms and 2026 guidance on November 12 earnings call could be a positive catalyst if economics are favorable
- Reliance Global Group↓ (OPPORTUNITY)◆
Entry into AI infrastructure via GPU cloud assets at a low $3M cash cost with no debt; if management scales the $1.5M revenue base, upside is significant, though dilution risk exists
- JATT II Acquisition Corp.↓ (OPPORTUNITY)◆
$120M all-stock merger with Talawar at $10.00 per share; if Nasdaq listing and minimum cash conditions are met, the combined company could attract attention—watch vote date
- Inflection Point Acquisition Corp. VI↓ (OPPORTUNITY)◆
Quantum Space Analyst Day on November 9 and effective S-4 position the deal for a near-term vote; space/defense technology focus could garner investor interest
- Kochav Defense Acquisition Corp.↓ (OPPORTUNITY)◆
Sponsor increased funding commitment to $300K upfront and $100K/month, and eliminated dissolution expense withdrawal—strong sponsor alignment may support extension approval on November 13
- FACT II Acquisition Corp.↓ (OPPORTUNITY)◆
Non-redemption agreements could reduce redemptions and preserve trust value; if extension passes, the SPAC gains a year to find a target—potential for deal announcement in 2027
- Haymaker Acquisition Corp V↓ (OPPORTUNITY)◆
Unit separation on November 9 allows separate trading of shares and warrants, potentially increasing liquidity and enabling warrant arbitrage—no deal yet but could precede announcement
- SPACCircle Acquisition Corp.↓ (OPPORTUNITY)◆
Unit separation on November 10 creates separate share and warrant trading; early-stage SPAC with no deal, but separation often precedes merger activity
- Ribbon Acquisition Corp.↓ (OPPORTUNITY)◆
EGM rescheduled to November 13; while procedural, the meeting may involve an extension or other proposal—watch for outcome
Sector Themes (6)
- SPAC Extension and Redemption Stress (SECTOR THEME)◆
5 of 15 filings involve SPAC extensions or meeting changes (Kochav, FACT II, Ribbon, Launch One, Future Vision II), with redemption prices around $10.81 and sponsor incentives to stem outflows—reflects a challenging market for blank-check vehicles nearing deadlines
- Stock-Based M&A in Small Caps (SECTOR THEME)◆
Abeona ($20M stock + milestones), JATT II ($120M all-stock), and ATII/Forge Nano (stock consideration) highlight a preference for equity consideration to preserve cash, often paired with private placements or earnouts
- Healthcare Services Consolidation (SECTOR THEME)◆
Park Dental's acquisition of Village Family Dental (12 practices, 47 doctors) continues the DSO roll-up trend, expanding into a fourth state with a focus on scale and local brand retention
- AI Infrastructure Entry via Small Acquisitions (SECTOR THEME)◆
Reliance Global Group's $3M GPU cloud asset purchase is a low-cost entry into AI infrastructure, but the tiny revenue base ($1.5M) underscores the challenge of scaling in a capital-intensive sector
- Governance and Listing Compliance Issues (SECTOR THEME)◆
Launch One (audit committee size, board independence) and Future Vision II (listing deficiency) received Nasdaq notices, while Flag Ship saw director dissent—signals heightened regulatory scrutiny for SPACs
- Board Turnover in SPACs (SECTOR THEME)◆
Roman DBDR and Launch One experienced director resignations in early November, with replacements appointed or pending—could indicate friction or normal course, but warrants monitoring
Watch List (8)
-
November 12 earnings release and November 13 call will disclose Village Family Dental deal terms and 2026 guidance—key for assessing acquisition impact [DATE: Nov 12-13]
-
EGM on November 13 to approve trust extension; sponsor increased funding commitment—watch shareholder approval and redemption levels [DATE: Nov 13]
-
EGM on November 17 to approve extension to November 25, 2027; redemption deadline November 13—watch for non-redemption agreements and redemption rate [DATE: Nov 13-17]
-
Rescheduled EGM on November 13; outcome may include extension or other proposals—monitor for any deal announcement [DATE: Nov 13]
-
Plans to start new Phase 3 for ABO-801 in Q2 2027; topline expected end-2028—watch for FDA feedback and trial design details [DATE: Q2 2027]
-
Quantum Space Analyst Day on November 9; S-4 effective October 28—shareholder vote likely soon, watch for date and redemption levels [DATE: Nov 9]
-
Nasdaq noncompliance notices; company intends to appoint new independent director—watch for appointment and cure within cure periods [DATE: TBD]
-
Item 3.01 listing deficiency—monitor for additional disclosures or cure plan; deal terms undisclosed [DATE: TBD]
Filing Analyses
(15)
09-11-2026
Kochav Defense Acquisition Corp. (KCHVU) filed an 8-K updating terms of its sponsor-funded trust extension ahead of a November 13, 2026 extraordinary general meeting to approve an Extension Amendment Proposal. The Sponsor (Kochav Sponsor LLC) will now contribute a flat $300,000 for the first 3 months post-approval (replacing a $0.06-per-unredeemed-share formula capped at $300,000) and $100,000 per month thereafter (replacing $0.02 per share capped at $100,000/month). Separately, the Company reduced the permitted trust interest withdrawal for dissolution expenses from $100,000 to $0, tightening protection of trust assets.
- · EGM scheduled for November 13, 2026 at 10:00 a.m. Eastern time
- · Record date for EGM voting eligibility: October 13, 2026
- · Definitive proxy statement filed with SEC on October 19, 2026
- · Each right entitles holder to one-seventh (1/7) of one Class A ordinary share upon consummation of initial business combination
- · Company was formerly named Star 52 Defense Acquisition Corp. (name change January 28, 2025)
- · Company is a Cayman Islands exempted company and an emerging growth company
- · Proxy solicitor: Laurel Hill Advisory Group, LLC (1-855-414-2266; [email protected])
- · SEC file number 001-42670; CIK 0002053799
09-11-2026
Reliance Global Group completed its all-cash acquisition of Oblivus's GPU cloud assets from Skyportal Inc. on November 3, 2026, marking its entry into the AI infrastructure market. The deal consists of $3,000,000 paid at closing plus up to $750,000 in revenue-milestone contingent payments ($375,000 escrowed), funded entirely from cash on hand with no stock issued, leaving the Company debt-free. The acquired business generated approximately $1.5 million in revenue for the twelve months ended September 2026 on unaudited seller records — a small base the Company aims to scale substantially, though it will require capital beyond the acquisition cash and may involve dilutive equity financings.
- · Founder stock consideration vests only if shares close at or above $5.00, $7.00 and $10.00 per share for three consecutive trading days, subject to Board approval
- · Acquisition executed through GPU Exchange Corp., a newly formed wholly-owned subsidiary
- · Closing occurred November 3, 2026, consistent with the timeline announced in October (transaction announced October 22, 2026)
- · Company explicitly warns growth plans, including GPU fleet acquisition, will require capital beyond acquisition cash and may be funded via dilutive equity financings
- · Risk factors cited include limited operating history in GPU cloud, potential loss of customers/GPU providers/key personnel, Nasdaq continued listing compliance, and GPU pricing/technological obsolescence
- · Ticker currently remains EZRA; effective date of XGPU change to be announced separately
- · Oblivus revenue figure is unaudited and management cautions it may not be indicative of future results
09-11-2026
FACT II Acquisition Corp., a Cayman Islands SPAC, filed an 8-K disclosing a shareholder meeting scheduled for November 17, 2026 to approve extending its business combination deadline from November 27, 2026 to November 25, 2027. The redemption price was approximately $10.81 per share based on a trust account of approximately $189,186,398.23 as of November 6, 2026, with the redemption deadline set for 5:00 p.m. ET on November 13, 2026. To stem redemptions, the sponsor intends to enter into non-redemption agreements transferring Class B (or converted Class A) founder shares to investors who forgo redemption — though the company explicitly states no assurances are made that any such incentive will be offered.
- · Extraordinary general meeting scheduled for November 17, 2026 at 10:00 a.m. Eastern Time
- · Redemption submission deadline is 5:00 p.m. Eastern Time on November 13, 2026
- · Definitive proxy statement filed October 14, 2026
- · Sponsor HoldCo would transfer Class B ordinary shares (or Class A upon conversion) to non-redeeming investors promptly following the business combination close, no later than two business days thereafter
- · Non-Redemption Agreements expected to increase funds remaining in the trust account relative to the absence of such agreements
- · Company explicitly states no assurances that any non-redemption incentive will be offered and actual terms may differ materially
- · Investor would use commercially reasonable efforts to purchase up to a to-be-determined number of Public Shares in the open market at a price no greater than the redemption price
- · Company is an emerging growth company; prior filings include Form 10-K (March 13, 2026) and Forms 10-Q (May 11, 2026 and August 12, 2026)
- · Proxy solicitor is Sodali & Co. (toll-free (800) 662-5200; banks/brokers (203) 658-9400)
09-11-2026
Flag Ship Acquisition Corp held its Annual General Meeting on November 6, 2026, with 2,853,595 ordinary shares present in person or by proxy, representing approximately 81.10% of shares issued and outstanding and constituting a quorum. Shareholders approved the election of all four director nominees (Matthew Chen, Shan Cui, Pai Liu, Wen He) and ratified Wei, Wei & Co., LLP as independent auditor for fiscal year ending December 31, 2026; the Adjournment Proposal was not presented because sufficient votes existed for the other proposals. Notably, director nominee Shan Cui, Pai Liu and Wen He each received 120,999 withheld votes (about 4.4% of votes cast), while Matthew Chen received only 994 withheld, indicating some shareholder dissent on three of the four nominees.
- · Record date for the AGM was September 10, 2026; proxy statement dated September 23, 2026
- · Broker non-votes of 77,392 on the Director Election Proposal
- · Auditor ratification passed with 2,852,601 for, 994 against, 0 abstentions
- · Adjournment Proposal was not presented to shareholders as sufficient votes existed for Proposals 1 and 2
- · Company is an emerging growth company (Rule 405/12b-2)
- · Company incorporated in Cayman Islands, Commission File Number 001-42138, principal offices at 26 Broadway, Suite 934, New York, NY 10004
- · Filing signed by Matthew Chen as CEO on November 9, 2026
09-11-2026
SPACCircle Acquisition Corp. announced that, effective November 10, 2026, holders of its IPO units may elect to separately trade the Class A ordinary shares, redeemable warrants, and rights bundled in each unit. The Class A shares, warrants, and rights are expected to trade on Nasdaq under the symbols SCQC, SCQCW, and SCQCR respectively, while unseparated units continue trading as SCQCU. The filing is a routine administrative update with no financial results or deal terms disclosed; the preliminary 'Merger/Acquisition' classification is not supported as no business combination was announced.
- · Separate trading commences November 10, 2026
- · Units not separated will continue to trade under symbol SCQCU on the Nasdaq Global Market
- · Holders must have their brokers contact transfer agent VStock Transfer, LLC to separate Units
- · Each Unit consists of one Class A ordinary share, one redeemable warrant, and one right
- · Each right entitles holder to receive one-half (1/2) of one Class A ordinary share upon consummation of the initial business combination
- · Press release dated November 6, 2026 filed as Exhibit 99.1
- · Company is an emerging growth company (checked)
09-11-2026
Roman DBDR Acquisition Corp. II disclosed in an 8-K that director Randolph C. Read resigned from the Board and its audit and compensation committees effective November 4, 2026, with the company stating the resignation was not due to any disagreement over operations, policies or practices. The Board filled the vacancies by appointing Bryn Sherman as chairperson of the Compensation Committee and Hunter Gary as a member of the Audit Committee, both effective November 4, 2026. No financial figures, deal terms, or merger-related details were disclosed in this filing.
- · Resignation and appointments were effective November 4, 2026; the 8-K was signed and dated November 6, 2026.
- · Company is an emerging growth company incorporated in the Cayman Islands with principal offices in West Palm Beach, FL.
- · Securities trade on Nasdaq under symbols DRDBU (units), DRDB (Class A shares) and DRDBW (warrants).
- · No merger or acquisition terms, target identity, or transaction timeline were referenced in this filing despite preliminary merger classification.
09-11-2026
Abeona Therapeutics acquired APT-1011 (renamed ABO-801), a Phase 3-ready once-daily oral fluticasone propionate tablet for eosinophilic esophagitis, from Ellodi Pharmaceuticals for $20 million in Abeona common stock with no upfront cash, plus up to $30 million on FDA approval, up to $30 million in sales milestones, and tiered royalties in the low-to-mid teens. Concurrently, Abeona entered a $30 million private placement of 6,400,000 shares at $3.75 and pre-funded warrants for 1,600,043 shares at $3.7499, with participation from Nantahala Capital, Marshall Wace, Monashee, Perceptive Advisors, TPG and other healthcare funds. However, the acquired asset's two completed Phase 3 studies (361 patients combined) both missed their prespecified co-primary patient-reported symptom endpoint, though they showed statistically significant improvements on several endoscopic measures; Abeona plans to start a new Phase 3 in Q2 2027 with topline data expected by end-2028.
- · Both completed Phase 3 studies of ABO-801 missed their prespecified co-primary patient-reported symptom endpoint, despite statistically significant improvements on several endoscopic measures
- · ABO-801 holds FDA Orphan Drug and Fast Track designations for EoE
- · Abeona must file a resale registration statement with the SEC no later than the 15th day after closing of the private placement
- · Net proceeds intended for general corporate purposes, pipeline development, and ZEVASKYN commercialization support
- · Morgan Stanley acted as sole placement agent
- · Securities in the private placement were not registered under the Securities Act
09-11-2026
Park Dental Partners (NASDAQ: PARK) completed its acquisition of Village Family Dental DSO on November 6, 2026, first disclosed August 10, 2026, expanding into North Carolina as its fourth state and adding 12 practice locations and 47 doctors. The deal brings Park to 270 affiliated doctors across 100 practice locations in Minnesota, North Carolina, Arizona and Wisconsin. However, the company did not disclose purchase price or financial terms, deferring details on the transaction's financial impact and 2026 guidance to its November 12 earnings release and November 13 call.
- · Village Family Dental was founded in 1985 and operates in eastern North Carolina markets including Fayetteville, Hope Mills, Eastover, St. Pauls, Raeford and Laurinburg
- · Acquired practices will continue operating under existing brands with local leadership remaining in place
- · Purchase price and financial terms of the acquisition were not disclosed
- · Financial impact of the transaction, including impact on 2026 guidance, will be shared at the November 12 earnings release and November 13 call
- · Park Dental Partners is headquartered in Roseville, Minnesota; its general dentistry group was established in 1972
- · Forward-looking statements flag risk that required North Carolina dental regulatory clearance may not be obtained or may be subject to conditions
- · Earnings call scheduled November 13, 2026 at 8:30 a.m. Eastern Time
09-11-2026
Launch One Acquisition Corp. received two Nasdaq noncompliance notices after Dr. Rodney A. Ferguson resigned from the board and its committees on November 4, 2026. The audit committee now has only two members (below the required three) and the board is no longer majority independent. The company intends to rely on Nasdaq cure periods and appoint a new independent director, but no replacement has been named and there is no assurance on timing.
- · Nasdaq notified the company of audit committee composition noncompliance on December 6, 2026.
- · Nasdaq notified the company of board independence noncompliance on November 6, 2026.
- · The compensation committee also has only two members, Mr. Atwood and Mr. Rogers.
- · Dr. Ferguson's resignation was effective immediately and was not due to any disagreement with the company.
- · The company is a blank check company incorporated in the Cayman Islands and an emerging growth company.
09-11-2026
Forge Nano Holdings, Inc. (the Purchaser) agreed on November 4, 2026 to acquire HzO, Inc. via a reverse triangular merger (FN Merger Sub, Inc. merging into HzO), with HzO surviving as a wholly-owned subsidiary; the 8-K was filed November 9, 2026. Consideration is stock-based — Company stockholders receive Consideration Shares of Purchaser Common Stock equal to the Purchase Price Amount divided by the Consideration Price Per Share, subject to adjustment and holdback shares, with no cash purchase price disclosed in the excerpt. The filing notes a prior March 13, 2026 Company Tranche 1 Investment into Forge Nano of $13,000,000 cash plus a $2,000,000 deemed unsecured loan in exchange for 76,116 Series D Preferred shares later converted to Purchaser Common Stock in the De-SPAC transaction.
- · Merger structured as a reverse triangular merger under Delaware General Corporation Law, with Merger Sub merging into HzO and HzO surviving as a wholly-owned subsidiary of Purchaser
- · Agreement dated November 4, 2026; 8-K filed November 9, 2026
- · Consideration consists of Consideration Shares of Purchaser Common Stock (Purchase Price Amount ÷ Consideration Price Per Share), with holdback shares and post-closing adjustment mechanics — no cash purchase price stated in the excerpt
- · Merger intended to qualify as a tax-free reorganization under Section 368(a) of the Code
- · Each Identified Employee entered into an employment agreement with Purchaser effective immediately after Closing, a condition to signing
- · Company stockholders' approval obtained via irrevocable written consent of directors and Significant Company Holders immediately following execution
- · Fortis Advisors LLC serves as Stockholders' Representative for the Company equityholders
- · Surviving corporation's charter and bylaws will mirror Merger Sub's, with name changed to HzO, Inc.
09-11-2026
JATT II Acquisition Corp. filed a DEFM14A proxy statement/prospectus for its business combination with Talawar, announced June 29, 2026, in which Merger Sub will merge into JATT and JATT will survive as a wholly-owned subsidiary of Talawar. Talawar stockholders will receive aggregate equity value of $120,000,000 paid entirely in Post-Closing Company Shares at a deemed value of $10.00 per share, while each outstanding JATT ordinary share converts into one Post-Closing Company Share. Closing is conditioned on Nasdaq listing approval, the Minimum Cash Condition, shareholder approvals and no material adverse effects, with termination rights including an Outside Date and 30-day cure periods; no financial performance or period-over-period operating metrics were disclosed in this excerpt.
- · Business Combination Agreement signed June 29, 2026 between JATT, Merger Sub and Talawar
- · All Talawar Convertible Instruments (including SAFEs) and Preferred Shares convert into Talawar Common Shares immediately prior to the Stock Split
- · Each outstanding and unexercised Talawar Option becomes an Exchanged Option on the same vesting and exercisability terms
- · No fractional Post-Closing Company Shares will be issued; share counts rounded down to the nearest whole share
- · Closing conditions include effectiveness of the Registration Statement, no SEC stop order, Talawar Stockholder Written Consent, Required JATT Shareholder Approval, and conditional Nasdaq listing approval
- · Talawar closing conditions include satisfaction of the Minimum Cash Condition and no JATT Material Adverse Effect
- · Termination permitted by mutual consent, for uncured breaches (30-day cure), or if not consummated by the Outside Date
- · Registration Rights and Lock-Up Agreement must be executed by Talawar stockholders holding 2% or more of shares and by CEO Marc Schegerin
- · JATT is a smaller reporting company/emerging growth company with reduced disclosure obligations
09-11-2026
Haymaker Acquisition Corp V filed an 8-K on November 9, 2026, announcing that holders of its IPO units (HYACU) may elect to separately trade the Class A ordinary shares and one-third redeemable warrants beginning November 9, 2026. Unseparated units will continue trading on the NYSE under 'HYACU', while the Class A shares and warrants are expected to trade under 'HAYC' and 'HYACW', respectively. No fractional warrants will be issued upon separation, and holders must have their brokers contact transfer agent Continental Stock Transfer & Trust Company to effect the split.
- · Units not separated will continue to trade on the NYSE under the symbol 'HYACU'
- · Class A ordinary shares expected to trade under 'HAYC' and warrants under 'HYACW' on the NYSE
- · No fractional warrants will be issued upon separation; only whole warrants will trade
- · Company is an emerging growth company (Rule 405 designation)
- · Company incorporated in Cayman Islands; IRS Employer Identification No. 98-1899739; Commission File Number 001-43476
- · Press release dated November 9, 2026 attached as Exhibit 99.1
09-11-2026
Ribbon Acquisition Corp. (Nasdaq: RIBB/RIBBU/RIBBR), a Cayman Islands SPAC, filed an 8-K disclosing that its Extraordinary General Meeting of Shareholders has been rescheduled from November 14, 2026 to November 13, 2026 at 10:00 a.m. Eastern Time. The record date remains February 18, 2026, and previously submitted proxies will still be voted at the rescheduled meeting unless revoked. The filing contains no financial figures, deal terms, or merger consideration details, and the preliminary 'Merger/Acquisition' tag is not supported by the disclosed content — this is a procedural meeting-date change only.
- · Extraordinary General Meeting moved one day earlier, from November 14, 2026 to November 13, 2026, both at 10:00 a.m. Eastern Time
- · Record date for voting eligibility remains February 18, 2026
- · Shareholders who already submitted proxies need take no further action unless they wish to revoke
- · Company is a Cayman Islands exempted company incorporated in E9 jurisdiction, SIC code 6770 (Blank Checks), SEC file number 001-42474, CIK 0002035016
- · Principal executive offices located at Central Park Tower LaTour Shinjuku, Room 3001, 6-15-1 Nishi Shinjuku, Shinjuku-ku, Tokyo 160-0023, Japan
- · Registrant qualifies as an emerging growth company and has not elected to opt out of the extended transition period
- · Filing signed by CEO Angshuman (Bubai) Ghosh on November 9, 2026; only Exhibit 104 (Inline XBRL cover page) was furnished
09-11-2026
Future Vision II Acquisition Corp. filed an 8-K on November 09, 2026 (Accession No. 0001829126-26-012116, 254 KB) disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, and/or transfer of listing, with Item 9.01 covering financial statements and exhibits. The filing summary provided does not disclose the merger counterparty, deal value, consideration structure, exchange ratio, premium, or any financial metrics; notably, the only substantive item flagged is a listing-standard/delisting notice, which is a negative governance/listing signal, while no positive deal economics were disclosed in the available summary. Investors should treat this as an informational/uncertain event pending review of the full filing text and exhibits.
- · Filing accession number: 0001829126-26-012116
- · Filing size: 254 KB
- · Item 3.01 indicates a continued listing rule deficiency or delisting notice - a negative listing-status signal
- · No merger counterparty, valuation, consideration, or exchange ratio disclosed in the provided summary
09-11-2026
Inflection Point Acquisition Corp. VI (IPFX) filed an 8-K under Regulation FD disclosing that merger target Quantum Space, LLC issued a press release announcing a Virtual Analyst Day on November 9, 2026 from 10:00-11:45 a.m. ET, featuring a management presentation and Q&A. The filing relates to the previously announced June 8, 2026 Business Combination Agreement among Inflection Point, IPFX PubCo, IPFX Merger Sub and Quantum Space, a developer of maneuverable spacecraft for national security and commercial missions. No financial figures or deal terms were disclosed; the S-4 registration statement (File No. 333-299286) was declared effective October 28, 2026, and the definitive proxy statement/prospectus has been mailed to shareholders ahead of the vote.
- · Virtual Analyst Day scheduled November 9, 2026, 10:00-11:45 a.m. ET, with live webcast and recording posted to investors.quantumspace.us
- · Business Combination Agreement originally entered into June 8, 2026
- · S-4 Registration Statement (File No. 333-299286) declared effective by the SEC on October 28, 2026
- · Definitive proxy statement/prospectus mailed to shareholders of record for the Business Combination vote
- · Quantum Space's Ranger vehicle is still in development and has not been manufactured, operated or sold to date
- · Forward-looking statements flag risks including shareholder redemption levels, financing availability, launch delays/failures, and government funding changes
- · Proxy solicitor Alliance Advisors reachable at 1-855-206-2037 or [email protected]
- · IPFX is an emerging growth company incorporated in the Cayman Islands, classified as a blank check company (SIC 6770)
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 15 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Merger & Acquisition SEC Filings
🇺🇸 More from United States
View all →November 10, 2026
US Pre-Market SEC Filings Roundup — November 10, 2026
US Pre-Market SEC Filings Roundup
November 09, 2026
US Pre-Market SEC Filings Roundup — November 09, 2026
US Pre-Market SEC Filings Roundup
November 09, 2026
US IPO Pipeline SEC S-1 Filings — November 09, 2026
US IPO Pipeline SEC S-1 Filings
November 09, 2026
US Executive Officer Management Changes SEC — November 09, 2026
US Executive Officer Management Changes SEC